Japan needs innovation to maintain pharma foothold
Although Japan's pharma market sits in firm second position on the global stage, the country's foothold is slipping as other more innovative countries grasp for a greater presence.
Archives for May 11, 2008
Hospira faces $35m charge over Morgan Hill plans
The decision to end manufacturing operations at its facility in Morgan Hill, California in the next three years may cost Hospira up to $35m (€22.7m), according to a document the firm filed with the US Securities and Exchange Commission (SEC).
Cambrex profits climb despite sales drop
Cambrex has experienced a jump in profitability for the first quarter 2008, despite a decrease in sales, assisted by previous cost-cutting initiatives.